{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-088225","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.651031+00:00","generated_at":"2026-06-17T07:40:52.279722+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Catalyst Pharmaceuticals board member Philip H. Coelho to retire at 2023 annual meeting","bullets":["Philip H. Coelho, independent director since 2002, will not stand for reelection.","Coelho serves as Chair of Nominating/Corporate Governance Committee and on Audit Committee.","Retirement is not due to any disagreement with the company.","He will continue as director until term expires at the 2023 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-088225","json":"https://secwatch.observer/filing/0001193125-23-088225.json","markdown":"https://secwatch.observer/filing/0001193125-23-088225.md","text":"https://secwatch.observer/filing/0001193125-23-088225.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312523088225/0001193125-23-088225-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312523088225/d469581d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T07:40:52.279722+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a5dd363b63","claim":"Philip H. Coelho retired as Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"On March 29, 2023, Philip H. Coelho, an independent member of the Board of Directors (“Board”) of Catalyst Pharmaceuticals, Inc. (the “Company”), advised the Company of his decision not to stand for reelection at the 2023 annual meeting of the Company’s stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312523088225/0001193125-23-088225-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}